Clinical Trial Update: Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing Vinorelbine/Gemcitabine versus Vinorelbine/Carboplatin in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)
• Paraplatin (Carboplatin)

Snippet

Sponsor: The Norwegian Lung Cancer Study Group | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED